944TiP - Pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma (rrPMBCL) or relapsed or refractory Richter syndrome (rrRS): Phase 2 KEYNOTE-170 study
| Autor: | Michot, J.-M., Armand, P., Ding, W., Ribrag, V., Christian, B., Balakumaran, A., Marinello, P., Chlosta, S., Zhang, Y., Shipp, M., Zinzani, P.L. |
|---|---|
| Zdroj: | In Annals of Oncology 1 October 2016 27 Supplement 6:vi325-vi325 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|